{
    "code": "02025229",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025229",
    "time": "2024-01-18 19:28:19",
    "許可證字號": "衛署藥輸字第025229號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/07\/07",
    "發證\/登錄日期": "99\/07\/07",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202522900",
    "中文品名": "磷減樂錠",
    "英文品名": "Renvela Film-coated Tablet",
    "適應症": "適用於控制接受透析治療的成年及6 歲以上孩童慢性腎病病人的高磷血症。",
    "劑型": "116膜衣錠",
    "包裝": "6-1000錠塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "ANHYDROUS SEVELAMER CARBONATE",
    "限制項目": "02輸　入",
    "申請商名稱": "賽諾菲股份有限公司",
    "申請商地址": "台北市信義區松仁路3號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "SANOFI WINTHROP INDUSTRIE",
            "製造廠廠址": "1,RUE DE LA VIERGE AMBARES ET LAGRAVE 33565 CARBON BLANC CEDEX, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "GENZYME CORPORATION",
            "製造廠廠址": "500 KENDALL STREET, CAMBRIDGE, MA 02142, U.S.A.",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200050620",
            "成分名稱": "ANHYDROUS SEVELAMER CARBONATE",
            "含量描述": "",
            "含量": "800.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Renvela_LPI_C_CCDS v7+pediatric indication+CCDS v8_sub 2020.04.24-109-05-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025229&Seq=008&Type=9"
        },
        {
            "title": "Renvela tab_bottle-104-09-04(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025229&Seq=002&Type=8"
        }
    ]
}